Newsletter | March 30, 2026

03.30.26 -- STREAM Insights Driving Innovation Across Pharma Development

Mastering The Art Of Developing A Successful Bispecific Antibody

Webinar | Abzena

Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design through to advanced, efficient purification techniques.

The Future Of Oral Solid Dose Development And Innovation

Video | Adare Pharma Solutions

Tom Sellig, CEO, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

Evolving Strategies In Large Molecule Manufacturing

Video | KBI Biopharma

Accelerate your biopharmaceutical program with a flexible, global manufacturing partner that minimizes risk, shortens timelines, and empowers seamless scaling from clinical to commercial production.

 

Navigating Regulatory Expectations For Injectable Packaging

Webinar | West Pharmaceutical Services, Inc.

Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

What Great CDMO Selection Looks Like In 2026

Video | Outsourced Pharma

This segment of the Outsourced Pharma Live event, “The Unfiltered Truth About CDMO Selection,” examines how experienced sponsors should redefine a “great” CDMO selection in 2026, moving beyond capacity and technical capability to focus on execution under uncertainty, the ability to manage change without contract disruption, right-first-time performance, and long-term business viability.

Minimizing Drug Product Loss In Manufacturing

Video | Eurofins

Explore how optimized analytical testing, reduced material wastage, and advanced sterile fill-finish technologies can work together to preserve valuable GMP material without compromising quality.

SPONSOR

Webinar: Less Risk, More Speed -The New Blueprint for Bioconjugate Development: A Fireside Chat

Bioconjugate development is evolving fast. In this Abzena fireside chat, discover how an integrated CDMO+CRO model reduces risk, removes roadblocks, and accelerates timelines for ADCs and emerging modalities. Gain practical playbooks, partner selection strategies, and fast-track frameworks to move from discovery to GMP with confidence, consistency, and speed without sacrificing quality or control. Click here to learn more.